Skip to search formSkip to main contentSkip to account menu

UK 52046

Known as: UK 52046-27, UK-52,046, UK-52046 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1992
1992
1. The dose-dependency of the alpha 1-adrenoceptor antagonist activity of the anti-arrhythmic abanoquil (UK-52,046) was… 
1991
1991
1. Abanoquil (UK 52,046) is a novel, quinoline-derivative, alpha 1-adrenoceptor antagonist which, on the basis of animal studies… 
1991
1991
Abstract— The effects of acute and chronic oral administration of UK‐52,046 (25 μg kg−1) on baroreflex function and its duration… 
1990
1990
1. In a placebo controlled study (six healthy male subjects), the effects of UK-52,046 (0.4 microgram kg-1 i.v.) and prazosin (0… 
1990
1990
Summary: The effects of increasing intravenous (i.v.) doses of prazosin, phenylephrine, flecainide, and UK- 52,046 on blood… 
1990
1990
The acute electrophysiological and haemodynamic effects of UK-52,046, a novel alpha 1-adrenoceptor antagonist (0.5 microgram kg-1… 
1990
1990
1. The haemodynamic effects of a new cardioselective postsynaptic alpha 1-adrenoceptor antagonist UK-52,046, were evaluated in 25… 
1990
1990
The effects of increasing intravenous (i.v.) doses of prazosin, phenylephrine, flecainide, and UK-52,046 on blood pressure (BP… 
1988
1988
1 Adrenaline‐induced arrhythmias in anaesthetized dogs respired with halothane were attenuated in 3 groups of 6 dogs by either UK…